AMGN compared with ADPT: revenue, margins and what each company keeps, and the suppliers and customers both name

AMGNAmgen Inc

Mkt capRevenueRevenue

ADPTAdaptive Biotechnologies Corp

Mkt capRevenueRevenue

Compare

AMGNAmgen Inc

ADPTAdaptive Biotechnologies Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

8 more · AMGN chain ›

Shared 0

No shared counterparties.

Only ADPT 6

PFEPfizercustomer

ILMNIlluminasupplier

—Fred Hutchinson Cancer Research Centerunlistedsupplier

—Genentech

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

unlistedcustomer

2 more · ADPT chain ›

AMGNAmgen Inc

460.55▲+0.06%· post 460.42

Mkt cap$249.0BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

ADPTAdaptive Biotechnologies Corp

27.97▲+4.25%· post 27.43

ClosedNov 6 '26

Mkt cap$4.5BRevenue$84MQ3 FY26Revenue$277MFY25

Compare

ClosedNov 6 '26

AMGNAmgen Inc

ADPTAdaptive Biotechnologies Corp

460.55▲+0.06%post 460.42

Price

27.97▲+4.25%post 27.43

$249.0B

Mkt cap

$4.5B

Q3 FY26$10.4B

Revenue

$84MQ3 FY26

FY25$36.8B

Revenue

$277MFY25

AMGN460.55▲+0.06%vsADPT27.97▲+4.25%ClosedNov 6 '26